This work provides a neurobiological framework which may facilitate the identification of biologically meaningful subtypes of depression, ultimately improving diagnosis and treatment and revealing sex-dependent networks within systemic inflammatory markers, which are in turn linked to sex-specific disease subtypes.
Abstract
Background: Major depressive disorder is a heterogeneous psychiatric condition, complicating clinical diagnosis and treatment. Efforts to stratify MDD have led to the utilization of systemic inflammatory and neuroimaging markers. Understanding of the relationship between these markers and how they correspond to depressive symptoms is crucial for identifying personalized metrics to rationally diagnose MDD. Methods: The CANBIND1 dataset comprising cohorts of people with MDD (n=211) and age-matched healthy controls (n=122) was used. Weighted gene co-expression network analysis (WGCNA) was applied to cluster multiplex ELISA cytokine data and identify inflammatory modules. Microstructural metrics were derived from diffusion-weighted imaging (DWI) in the same individuals. The relationships among inflammatory modules, imaging markers, and clinical features were examined using correlation analysis. Results: We demonstrate that networks of peripheral inflammatory markers relate to specific depressive symptoms. Additionally, these cytokine networks are associated with diffusion MRI metrics of tissue microstructure, especially the correlated diffusion index (CDI). Distinct patterns were observed in patients compared to age-matched controls. Notably, these associations are more pronounced in gray matter than white matter, and more in females than in males. Conclusion: Our findings reveal sex-dependent networks within systemic inflammatory markers, which are in turn linked to sex-specific disease subtypes. This work provides a neurobiological framework which may facilitate the identification of biologically meaningful subtypes of depression, ultimately improving diagnosis and treatment.
This study provides a data-driven characterization of cognitive heterogeneity in MDD, identifying two cognitive dimensions spanning from relative preservation to widespread impairment, and provides preliminary biological context for interpreting cognitive heterogeneity in MDD.
Yu-Shun Yan, Jia'ao Yu, Liang Zuo et al.· Psychiatry and Clinical Neur...· 0 citations
This research deepens the understanding of the biological diversity of MDD, providing a biologically grounded framework for stratifying patients, which may inform the future design of hypothesis‐driven clinical trials targeting specific cognitive or sensorimotor circuits.
Xiao-Zheng Liu, Zhong-Wei Guo· Depression and Anxiety· 0 citations
Peripheral lipid and antioxidant-related biomarkers may help contextualize brain abnormalities across psychiatric disorders, but their relationships with brain structure, intrinsic activity, and dimensional symptoms remain incompletely characterized. In this cross-sectional study, 93 adults were recruited: 38 with majo...
H. Wu, C. Yang, Y. He et al.· medRxiv· 0 citations
This study delineated two MDD subtypes with distinct neuropathological profiles: one characterized by structural abnormalities across multiple brain regions and the other by widespread functional disruptions.
Z. Chen, Q. Bo, C. Wang· International Journal of Neu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.